<html xmlns="http://www.w3.org/1999/xhtml"><head>
        <meta http-equiv="Content-Type" content="text/html; charset=utf-8">
        <meta name="viewport" content="width=device-width, height=device-height, initial-scale=0.5, minimum-scale=0.5, user-scalable=yes, maximum-scale=2.0, target-densitydpi=device-dpi" />
				<meta name="robots" content="all"/>
        <meta name="description" content="description">
        <meta name="keywords" content="">
        <title>Page 251 - MIMS April 2020 E4</title>
<style type="text/css">
<!--
body {
	margin-left: 0px;
	margin-top: 0px;
	margin-right: 0px;
	margin-bottom: 0px;
}
  
#container {margin:50px auto;padding:0px;width:910px;}
#left-button{ width:90px; height:100%;float:left }
#middle{ width:730px; margin:0px; float: left;}
#right-button{ width:90px; float:left;}
html, body, div, ul, li, dl, dt, dd, h1, h2, h3, h4, h5, h6, form, input, dd,select, button, textarea, iframe, table, th, td { margin: 0; padding: 0; }
img { border: 0 none; displayblock}
span,ul,li,image{ padding:0px; margin:0px; list-style:none;}
#top-title{ width:714px; margin-bottom:10px; float:left; padding:0px 8px}
#top-title2{ width:320px;  float:right;}
#content{ width: 730px; float:left;float:left;word-wrap: break-word;}
#content-top{ width:730px; background-image:url(images/top_bg.jpg); height:56px; background-repeat:no-repeat; float:left;}
#content-top1{ width:70%; padding:16px 0px 0px 30px; font-family:Arial, Helvetica, sans-serif; font-size:24px; color:#636363;float:left;}
#content-top2{ width:60px; float:right; padding:25px 30px 0px 0px;font-family:Arial, Helvetica, sans-serif; font-size:11px; color:#2f2f2f; font-weight:bold; text-align:right}
#content-middle{ width:730px; background-image:url(images/middle_bg.jpg); background-repeat:repeat-y;float:left;}
#content-middle1{ width:475px; padding:25px 0px 25px 35px; font-family:Arial, Helvetica, sans-serif; font-size:12px; color:#636363; line-height:150%;float:left;}
#content-middle2{  padding:7px; float:right; margin:25px 35px 0px 0px; border:solid 1px #c8c8c9; background-color:#FFF; text-align:center}
#content-bottom{ width:730px; background-image:url(images/bottom_bg.jpg); background-repeat:no-repeat; height:58px;float:left;}
#content-bottom2{ width:110px; height:42px; margin:0px auto; padding-top:4px;}
#input{ width:58px; height:20px; background-color:#FFF; border:solid 1px #dfdfe0; color:#636363; text-align:center; font-size:11px;}
.font1{ font-family:Arial, Helvetica, sans-serif; font-size:10px; color:#2f2f2f;}
.font1 a:link{
	text-decoration: none;
    color:#2f2f2f;

}
.font1 a:visited{
	text-decoration: none;
    color:#2f2f2f;
	
}
.font1 a:hover{
	color: #2f2f2f;
	text-decoration: underline;

}



.text-container {
padding: 20px;
color: #333;
margin-top: 24px;
line-height: 22px;
border-top-left-radius: 3px;
border-top-right-radius: 3px;
}

.use-as-video {
float: right;
padding-left: 20px;
}
.cc-float-fix:before, .cc-float-fix:after {
content: "";
line-height: 0;
height: 0;
width: 0;
display: block;
visibility: hidden;
}
.use-as-video-img {
cursor: pointer;
position: relative;
width: 320px;
height: 180px;
}
.use-as-video-title {
font-size: 15px;
font-weight: bold;
color: #000000;
padding-bottom: 5px;
}
-->
</style>
<script type="text/javascript">
<!--
function MM_preloadImages() { //v3.0
  var d=document; if(d.images){ if(!d.MM_p) d.MM_p=new Array();
    var i,j=d.MM_p.length,a=MM_preloadImages.arguments; for(i=0; i<a.length; i++)
    if (a[i].indexOf("#")!=0){ d.MM_p[j]=new Image; d.MM_p[j++].src=a[i];}}
}

function MM_swapImgRestore() { //v3.0
  var i,x,a=document.MM_sr; for(i=0;a&&i<a.length&&(x=a[i])&&x.oSrc;i++) x.src=x.oSrc;
}

function MM_findObj(n, d) { //v4.01
  var p,i,x;  if(!d) d=document; if((p=n.indexOf("?"))>0&&parent.frames.length) {
    d=parent.frames[n.substring(p+1)].document; n=n.substring(0,p);}
  if(!(x=d[n])&&d.all) x=d.all[n]; for (i=0;!x&&i<d.forms.length;i++) x=d.forms[i][n];
  for(i=0;!x&&d.layers&&i<d.layers.length;i++) x=MM_findObj(n,d.layers[i].document);
  if(!x && d.getElementById) x=d.getElementById(n); return x;
}

function MM_swapImage() { //v3.0
  var i,j=0,x,a=MM_swapImage.arguments; document.MM_sr=new Array; for(i=0;i<(a.length-2);i+=3)
   if ((x=MM_findObj(a[i]))!=null){document.MM_sr[j++]=x; if(!x.oSrc) x.oSrc=x.src; x.src=a[i+2];}
}
//-->
</script>
</head>

<body onload="MM_preloadImages('images/next2.png','images/previous2.png')">
<div id="container">
<div id="left-button">
  <p>&nbsp;</p>
  <p>&nbsp;</p>
  <p>&nbsp;</p>
  <p>&nbsp;</p>
  <p>&nbsp;</p>
  <p><a href="page250.html"><img src="images/previous_big.png" width="90" height="80" /></a></p>
</div>
<div id="middle">
  <div id="top-title"><span class="font1">Basic HTML Version</span>
    <div id="top-title2">
      <table width="100%" border="0" align="right" cellpadding="0" cellspacing="0">
        <tr>
        	<td width="66%"> </td>
          <td width="35%" style="display:none" align="right"><img src="images/content.png" width="19" height="16" /></td>
          <td width="31%" style="display:none" class="font1"><a href="">Table of Contents</a></td>
          <td width="6%"><img src="images/view.png" width="19" height="16" /></td>
          <td width="28%" class="font1"><a href="../../MIMS April 2020 E4.html#p=251">View Full Version</a></td>
        </tr>
      </table>
    </div>
  </div>
  <div id="content">
     <div id="content-top">
        <div id="content-top1">Page 251 - MIMS April 2020 E4</div>
        <div id="content-top2">P. 251</div>
     </div>
     <div id="content-middle">
     	
     	  <div class="text-container">
    <div class="use-as-video cc-float-fix">
      <a style="text-decoration: none;" href="../../MIMS April 2020 E4.html#p=251"><img src="../thumb/251.jpg" /></a>
    </div>

    <p class="use-as-video-title"></p>
    <pre style="white-space:pre-line"><code>214 / 2020-04                                                             Urinary System - 16.5
                                Contraindications: Pregn.& lactat., childr.und. 18 yrs., known al-  N&V, diarrh., constipat., dry mouth, pancreatit., abnorm. liv.enzyme
   16.5   Others                lergy to starch bas.polymers, maltose/ isomaltose intol., glycogen   lev., orthostat.hypotens., syncope, angioed., epistax., dyspn., nas.
                                                              congest., hypersens. reacts.incl.Stev.Johns.syndr., diaphores., li-
                                stor.dis., abdom. surg. dur.preced.month, abdom.fistulae/ tumours/
          (See also 5.3, 5.4)   open wounds/herniae/other condits. compromis. integrity of abdom.  chen plan., alopec., tinnit., vertigo, decr. libido. chest pain, halluci-
   BETMIGA (MDR Listing)        wall/-surf/intra-abdom.cav., ac.ren.fail., condits. preclud.norm. nutrit.,   nat., depress., urin. freq./incont., arthralg. Freq.unknown: Priapism,
                                        +
   TAMSUL (MDR Listing)         imp.resp.funct., K  defic.    palpitat., tachycard., artr.fibrillat., dysrhythm., blurr.vis., red. sclera,
                                Side effects: Electrol.lev.changes, periton. reacts. incl.abdom.pain,
   URISPAS (MDR Listing)        cloud.effluents with/-out bact., asthen., headache, hyper-/hypotens.,   Warnings and special precautions: Advise pt. on poss.orthos-
                                                              tat.hypotens., thorough examin. bef. init. ther.to excl.other condit.
   BENIPROSIN SR, (Unicorn) Ranbaxy [P/S]  hypo-/hypervol., oed., dizzin., skin rash, exfoliat., dehydrat. partic.  caus.same sympt., digit.rect.exam.& determ.PSA bef.& reg.aft.,
   Tamsulosin HCl.              elderly from enhanc.ultrafiltrat., poss. neurologic.sympts., hypogly-  intraoperat. floppy iris syndr.report.dur.cataract surg. incr.risk of
   Indications: Funct.sympts.of benign prostat. hyperplas.(BPH)  caem.in diabet., loc. reacts. around catheter, effs.relat.to proced.,   procedur.complicat. dur.cataract surg., pre-op assessm.of cataract
   (S4) SR CAPS, A40/34/0211    hernia of abdom.cavity, ileus, loss of appet., dyspeps., N&V, fatig.,   surg.pts., ren. impairm., if drowsin./dizzin.exper.do not driv./ operat.
   716778-001: 0,4 mg, 30, R169,17  shoulder pain, faint., musc. cramp., resp.sympts.assoc.with shortn.  machin., concom. mod.CYP3A4 inhibits./ strong or mod. CYP2D6 in-
   Dosage: Swall.whole while in stand./sitt.posit. Do not crush/chew.  of breath & weakn.  hibits./pts.who are CYP2D6 poor metabolis., for males only, safety
   1 cap.dly.aft.breakf.        Special precautions: Adeq.contracept.in women of child bear.  in pregn.& lactat.not est.
   Contraindications: Orthostat.hypotens.hist., hepat.insuffic., use   potent., monit pts.to avoid over/und. hydrat., keep.accurat.fluid bal.  Interactions: Other alpha 1-adrenocept.block. exacerb. hypotens.
   in females.                  records & monit body weight, monit.bld.chem/haematol.& plasma   eff., cimetidine incr. plasma lev., furosem.decr.expos.but cnonc.re-
   Side effects: Hypersens.reacts., angio-oed., dizzin., headache,   osmolality.reg., poss.replacem.of prot./amino acids/ water sol.vits./  main within norm. range, diclofen.& warfar.may incr.eliminat. rate.
   postur.hypotens., palpitat., syncope, rhinit., GI disturbs., abnorm.  meds., poss.insul.dos. adjustm. in diab.mellit.when transf.from gluc.
   ejaculat., priapism, asthen.  base periton. dialys., monit.serum elctrol.levs.recomm., inspect. drain.  PHYSIONEAL 40 GLUCOSE, AI Crit.Care [P/S]
   Special precautions: Only for male pts., thorough examin.bef.  fluid for pres.of fibrin/cloudin.which may indic.infect./ asept.peritonit.,   (S1) PERITON.DIALYS.SOL, 1,36%w/v/13,6 mg/ml 37/34/0584
   init.ther.to excl.other condit. caus.same sympt., determ.PSA bef.&   discont.& analyse fluid if cloudin. pres,if fluid clears after withdr. &   Final sol.aft.mix.Bags “A” &”B”: Anhydr.gluc. 13,6 g, Na Cl 5,38 g,
   reg. aft., pt.to sit/lie down when first sympt.of orthost. hypotens.  other reasons for cloudin.excl.re-chall. und. close medic.supervis.  Ca Cl dihydr.0,184 g, Mg Cl hexahydr.0,051 g, sod.bicarb.2,10 g,
   occur., inoperat.floppy iris syndr. assoc.with alpha-1 blocks observ.  poss.but if cloudy fluid recurs alternat.periton. dialys.ther.to be init.&   sod.lact. 1,68 g/L
                                        +
   dur. cataract surg.          pt monit., monit.K  & Ca lev.of pts.on card.glycos., take into acc.pH   (S1) PERITON.DIALYS.SOL, 2,27%w/v/22,7 mg/ml 37/34/0585
   Drug interactions: Incr.plasma lev.with cimetidine, decr.plasma lev.  & salts of solut., do not warm bag by immers.in warm water, check   Final sol.aft.mix.Bags “A” &”B”: Anhydr.gluc. 22,7 g, Na Cl 5,38 g,
   with furosemide, diclofen.& warfar.may incr.eliminat.rate, hypotens.   drug compatibil. bef. admix.  Ca Cl dihydr.0,184 g, Mg Cl hexahydr.0,051 g, sod.bicarb.2,10 g,
   effs.with concom.other alpha 1-adrenocept. antagon.  Warnings: Bld.gluc.monit.must be done with a gluc. specif.method   sod.lact. 1,68 g/L
                                to prev.maltose interfer.which may caus.false read. Ref.to prod.leaf.of   (S1) PERITON.DIALYS.SOL, 3,86%w/v/38,6 mg/ml 37/34/0586
   BETMIGA, Astellas [P/S] &    gluc.test kit., bld.conc.of dialys.drugs poss.reduc.by dialys.  Final sol.aft.mix.Bags “A” &”B”: Anhydr.gluc. 38,6 g, Na Cl 5,38 g,
   Mirabegron                                                 Ca Cl dihydr.0,184 g, Mg Cl hexahydr.0,051 g, sod.bicarb.2,10 g,
   Indications: Sympt.treatm.of urin.urg./incr. micturit. freq. &/urg.  FLOMAX, Astellas [P/S]  sod.lact. 1,68 g/L
   incont.in adult with overact. bladder (OAB) syndr.  Tamsulosin HCl.  Indications: Whenever peritoneal dialysis employ., where sols.
   (S3) TABS, 47/16.5/0297, 0298  Indications: Funct.sympts.of benign prostat. hyperplas.(BPH)  bas.on lact.buffer only& low pH cause abdom.inflow pain/discomf.
   722475-001: 25 mg, 30, R443,45  (S4) SR CAPS, 30/34/0428   706199-001: 13,6 mg/ml, 2 000 ml, 4, R721,05
   722789-001: 50 mg, 30, R443,45  840599-005: 0,4 mg, 30, R363,47  706199-002: 13,6 mg/ml, 2 000 ml, 1, R167,65
   Dosage: Recomm.dos: 50 mg once dly.  Dosage: Swallow whole  706198-001: 22,7 mg/ml, 2 000 ml, 4, R170,20.
   Contraindications: Hypersens., sev.end-stage ren.impairm., sev.  1 cap.dly.aft.breakf./ first meal of the day.  706189-001: 38,6 mg/ml, 2 000 ml, 4, R174,20
   hepat.impairm, sev.uncontroll. hypertens., sev.ren.impairm./mod.  Contraindications: Hypersens., orthostat. hypotens.hist., hepat.in-  Dosage: Intraperiton.admin.& sngl.use only using asept.techniq.
   hepat.impairm. receiv.concom. strong CYP3A inhibits.  suffic., concom.strong inhibits. of CYP3A4, e.g. ketoconaz.  throughout. Warm in overpouch. to body temp.bef.use.then break
   Side effects: Tachycard., UTI, dizzin., somnol., insomn., blurr.vis.,   Side effects: Dizzin., headache, palpitat., atrial fibrillat., dysrhythm.,   interchamb. pin to mix.the two sols. Infus. within 24 hrs.aft.mix.
   eyelid/lip oed., palpitat.,atrial. fibrillat., GI disords., urticar./macul./  tachycard., dyspn., orthostat. / post.hypotens., resp./thorac.& medi-  Mode of ther./freq./exchange vol & length of dialys. to be determin.
   papul.rash, prurit., leukocytoclast. vasculit., purpura, joint swell.,   astin. disords., rhinit., GI disturbs., skin & subcutan. disords. incl.Stev.  by physis. Select sol.with low. osmolarity lev.consist.with fluid remov.
   vulvovagin. prurit., incr. BP/GGT/AST/ ALT, hypertens.cris., angioed.,   John.syndr., abnorm.ejaculat., priapism, asthen., syncope, angio-oed.,   requirem. of each exchange. Aveg.freq: 4-5x/ day. Fill vol.depend.on
   urin.retent., headache.      intraoperat. floppy iris syndr.dur.cataract surg.  body size: usual.2,0-2,5 L.
   Warnings and special precautions:. Pregn.& lactat., safety & ef-  Special precautions: Thorough examin.bef.init. ther.to excl.  Contraindications: No absol.contra-indicat. but gen. not advis.in:
   fic.in childr.&lt;18 yrs.not est., sev. ren. impairm., meas.BP at baseline   other condit.caus.same sympt., determ. PSA bef.& reg.aft., intend.  ser.condits.affect abdom. wall/ abdom.cav., sev.resp.insuffic., mal-
   & periodic.dur. treatm., limit.data in in pts.with stage 2 hypertens.,   for males only, sev. ren. impairm., init.ther.in pts.sched.for cataract.   nutrit., sev. lipid metabol.disords., no clinic.exper.in pregn. & lactat.
                                surg.not recomm., meas.to be in place to manage poss.intraoperat.
   congenit./acquir.QT prolongat., concom. digox.             Side effects: Effs.relat.to proced: abdom.pain, bleed., peritonit., in-
   Drug interactions:. AUC incr.with concom. ketoconazole, concom.  floppy iris syndr.dur. cataract surg., caut.with concom.mod.inhibits.  fect.around cathet., cathet. block., ileus shoulder pain, abdom.cavity
                                of CYP3A4, e.g. erythromyc.
   meds.with narr.therapeut. index & signif.metabolis.by CYP2D6 incl.   hernia. Effs.relat.to sols: Weakn., tiredn., musc. cramp., headache,
   thioridazine/ haloperidol/risperidone/Type 1C antidysrhythm/ TADs.,   Drug interactions: Diclofen.& warfar.may incr. eliminat. rate, hypo-  faint., pulm.oed., electrol. disturbs.
   concom.CYP2D6 substrat. that are individ.dose titrat., consid.potent.  tens.effs.with concom.other alpha1-adrenocept.antagon., incr.expos.  Special precautions: Check drug compatibil. bef. admix., consid.
                                with strong inhibits.of CYP3A4 e.g. ketoconaz.
   for P-gp inhibit.with concom.sens. P-gp substrat.incl. dabigatran.  poss.losses in bld.conc.of dialysable drugs, monit.K  lev.of pts.on
                                                                                    +
   See also MDR page 204.       NUTRINEAL PD4 WITH 1.1% AMINO ACIDS, AI Crit.Care [P/S]  card. glycos. as digit.intoxic.risk exists, poss K  supplementat., accur.
                                                                                 +
   CYSTISTAT, Pharmaco          L-Tyrosine 0,300 g, L-Tryptophan 0,270 g, L-phenylalanine 0,570 g,   fluid bal.& body weight records to avoid over-/underhydrat., poss. re-
   Sodium hyaluronate           L-threonine 0,646 g, L-Serine 0,510 g, L-Proline 0,595 g, Glycine   placem. of prot./amino acids/water sol.vits., monit. ser.electrol.conc./
                                0,510 g, L-Alanine 0,951 g, L-Valine 1,393 g, L-Methionine 0,850 g,
   Indications: Temp.replacem.of the glycosaminoglycan layer in bladd.  L-Isoleucine 0,850 g, L-Leucine 1,020 g, L-Lysine (as HCl) 0,955 g, L-  bld.chem.& haematol. paramet., poss.insul.dos/treatm.adjustm.in
   assoc.with radiat.ther.      Histidine 0,714 g, L-Arginine 1,071 g, CaCl as dihydrat. 0,184 g, MgCl   diab. mellit., hyperparathyroid.poss.worsen as Ca content low, monit.
   (S4) SOL, A40/18.10/0062. 40 mg/50 ml.  hexahydrat. 0,051 g, Na lact. 4,48 g, NaCl 5,38 g/1 000 ml. 2L bag   bicarbon.lev.with concom. antacids & Ca carbon.
   3000270-001, 1x50 ml, R1 730,53  provides 22 g amino acids equiv.to 0,30 g/kg/ day for 70 kg adult.  PYRIDIUM, Biotech
   Dosage: For admin.by a medic.practit.only. Instil entire vol.of sol.  Indications: Nutrit.supplem.for malnourish. ren. fail.pts.(albumin   Phenazopyridine
   into bladd.aft.any resid.urine remov. Retain.in bladd.for as long as   Indications: Symptomat.pain relief of low.urin. tract irrit.
   poss.(min.30 mins.).         conc.low.than 35 g/litre) maint. on peritoneal dialys.  (S2) TABS, H/18/1728
                                (S1) PERITON.DIALYS.SOL, 37/34/0234
   Recomm.use: Instill.into bladd each wk for 4–12 wks. & then   706480-001: 1x2 L, R290,91  758647-034: 100 mg, 20, R69,13
   mnthly.until sympts.resolv.  706480-002: 5x2 L, R1 420,74  Dosage: Treatm.not to exceed 2 days if antibact. admin.concurr.
   Contraindications: Childr., pregn & lactat.  Dosage: Intraperiton.admin.only using asept. techniq.throughout.   Adults: 2 tabs.3xdly.
   Side effects: Irrit.bladd.sympts., haematur., infects., irrit.rash., ad-  Remove from overpouch & warm to body temp.bef.use. Use within   Contraindications: Glomerulonephrit., uraem., imp.ren.funct., sev.
   min.site dermatologic. manifestat.  few hrs.of open.       hepatit., rep./prolong.use without full diagnost.investigat., incr.risk of
   Warnings and special precautions: Discont.if adv. reacts.  Dos.sched./ freq./durat.of dwell to be determin. by physic  sev. haemolyt.anaem.in G6PD defic.
   experienc.                   Recomm.diet.prot.allow: Dialys.adults: approx. 1,2-1,3 g/kg. Infts:   Side effects: Headache, GI disturbs., hypersens. reacts.incl.ana-
   DETRUNORM, Litha Pharma (Pty) Ltd  2-3 g/kg. High.amnts.poss. necess.in sev.catabol.states. Re-eval.  phylact.react., bld.dyscras., vis. disturbs., ren.calculi, jaund., body
   See Section 5.4              treatm. aft.3 mnths.if no chem./biochem.improvem.  fluid discol.
                                Contraindications: Rec.abdom.surg.& GI disturbs.but consid be-  Special precautions: Infect.to be treat., symptomat. treatm.not
   ENABLEX, Aspen Pharmacare (Pty) Ltd  nef.vs.risk in each case, uraem.high.than 38 mmol/L, safety & effic.  to delay definit.diagnos.
   See Section 5.4              in childr.not assess., no evid.of safety in pregn.,   RANTRAL MR, Ranbaxy (SA) Pty Ltd
   EXTRANEAL, AI Crit.Care [P/S]  Side effects: Peritoneal infects., electrol.& fluid imbal., metabol.  See Section 7.3.2
   Icodextrin 75 g, NaCl 5,4 g, Na lactat. 4,5 g, CaCl 0,257 g, Mg Cl   acidos., hyperazotaem.  +
                                Special precautions: Check drug compatibil. bef.admix., monit.K
   0,051 g/1 L.                                               RENVELA, (Sanofi) Genzyme Biopharm [P/S]
   Electrol.cont: Na 133 mmol, Ca 1,75 mmol, Mg 0,25 mmol, Cl   lev.of pts.on digital., caref. monit.of insul.dos/hypoglycaem.treatm.  Sevelamer carbonate
                                of diab.mellit., uncorrect.acidos., sev.hepat.fail., hyperammonaem.,
   96 mmol, lactate 40 mmol/1 L  amino acid hypersens., monit.fluid/electrol./acid base bal.& changes   Indications: Adult hyperphosphataem.in haemodialys./periton.
   Indications: Once dly.replacem.for sngl.gluc. exchange for 6-12 hrs   in N 2 bal., poss.adapt.to other concom.meds.dos.  dialys. & adult chron.kidney dis. (CKD) pts.not on dialys.with ser.
   as part of CAPD/APD regimen for treatm.of chron.ren.fail. May be   phosphor. &gt; 1.78 mmol/L.
   used where effic.of ultrafiltrat.on gluc.sol.no long. effect.  OMSAL, Litha [P/S]  (S4) TABS, 45/32.16/0305
   (S3) PERITON.DIALYS.SOL, 38/34/0172  Tamsulosin HCl.       720512-001: 800 mg, 180, R2 610,36
   707038-001: 2 000 ml, 2 L contain., R339,11.  Indications: Funct.sympts.of benign prostat. hyperplas.(BPH).  Dosage: Do not crush, chew or break tabs. Admin. 3x/day with meals.
   Dosage: Intraperiton.admin.only using asept. techniq.throughout.   (S4) MODIF.REL.CAPS, 42/18.10/0538  Recommend.starting dos: 2,4 - 4,8 g /day based on clinic.needs
   For use dur.long.dwell period. Sngl.use only. Warm in overseal.bag.  718715-001: 0,4 mg, 30, R247,95  & phosphor.lev.
   to 37 °C bef.use.using spec.design.warm.plate.  Dosage: Swallow whole in stand./sitt.posit. Do not crush/chew.   Pts.prev.on phosph.binders: Admin.on gram for gram bas.with
                                          st
   Adults: Limit.to sngl.exchange in each 24 hr. period. Admin.over 10-  1 cap. dly. aft.breakf.1  meal of the day. Admin.dos. same time dly.  monitor.of ser.phosphor.levs.to ensure optim.dly.dos..
   20 mins.at rate comfort.to pt. For norm. body size vol.instill.not to   Contraindications: Orthostat.hypotens.hist., hepat. insuff., concom.  Maint: Monit.ser.phosphor.lev.& titrat.dos.every 2 - 4 wks. until ac-
   exceed 2 L and 2,5 L in larg pts.(more than 70-75 kg). If instill. vol.  strong CYP3A4 inhibits.  cept.ser.phosphor.lev reach.& thereaft.on a reg.basis. In clinic.pract
   causes discomf.reduc.vol. instill. Recomm. dwell time is 6-12 hrs. in   Side effects: Freq: Headache, dizzin., rhinit., abnorm. ejaculat., as-  treatm.will be contin.bas.on need to contr.ser.phosphor.lev.& dly.dos.
   CAPD & 14-16 hrs.in APD.     then., malaise. Less freq: Insomn., drowsin., nervousn., paraesthes.,   is expect.to be an aveg.of approx. 6 g/day.</code></pre>
     	</div>
    
     </div>
     <div id="content-bottom">
       <div id="content-bottom2">
         <table width="110" border="0" cellspacing="0" cellpadding="0">
           <tr>
             <td width="22%" height="44"><a href="page250.html"><img src="images/previous.png" width="26" height="19" id="Image2" onmouseover="MM_swapImage('Image2','','images/previous2.png',1)" onmouseout="MM_swapImgRestore()" /></a></td>
             <td width="43%">
             	&nbsp;&nbsp;&nbsp;<a href="page246.html">246</a>&nbsp;&nbsp;&nbsp;<a href="page247.html">247</a>&nbsp;&nbsp;&nbsp;<a href="page248.html">248</a>&nbsp;&nbsp;&nbsp;<a href="page249.html">249</a>&nbsp;&nbsp;&nbsp;<a href="page250.html">250</a>&nbsp;&nbsp;&nbsp;<a href="page251.html">251</a>&nbsp;&nbsp;&nbsp;<a href="page252.html">252</a>&nbsp;&nbsp;&nbsp;<a href="page253.html">253</a>&nbsp;&nbsp;&nbsp;<a href="page254.html">254</a>&nbsp;&nbsp;&nbsp;<a href="page255.html">255</a>&nbsp;&nbsp;&nbsp;<a href="page256.html">256</a>
             </td>
             <td width="35%"><a href="page252.html"><img src="images/next.png" width="26" height="19" id="Image1" onmouseover="MM_swapImage('Image1','','images/next2.png',1)" onmouseout="MM_swapImgRestore()" /></a></td>
           </tr>
         </table>
       </div>
     </div>
  </div>
</div>
<div id="right-button">
  <p>&nbsp;</p>
  <p>&nbsp;</p>
  <p>&nbsp;</p>
  <p>&nbsp;</p>
  <p>&nbsp;</p>
  <p><a href="page252.html"><img src="images/next_big.png" width="90" height="80" /></a></p>
</div>


</div>

</body>
</html>
